HELSINKI, Finland – Oct. 24, 2012 -- Nexstim was among the 25 selected innovative entrepreneurs that presented to a delegation of 100 leading global industry players and representatives from cross-venture capital and global investment firms in the Medtech Summit 2012 on the 16th- 17th of October in Lausanne, Switzerland. The Medtech Summit was third of its kind, organized by The European Tech Tour Association, an independent not-for-profit organization committed to the development of emerging technology companies from Europe.
The objective of the Medtech summit is to identify the upcoming and leading top high-growth privately held medtech companies in Europe and to introduce them to key European, US and Asian investors and professionals who can assist in their global expansion. "We are very proud to be among the selected companies. It is a great opportunity to present our company to distinguished investors from Europe, Asia and US", says Janne Huhtala, CEO of Nexstim, who presented in the summit.
The Medtech Summit is recognized by the investment community as a highly effective catalyst which allows expanding companies to bring forward innovative therapies. Estimated investment capabilities of attending investors in the Medtech Summit 2012 are estimated to 5 billion+ Euros.
Link to the press release on companies selected to present in Medtech Summit 2012:
Link to Medtech Summit 2012 pages: